BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29045731)

  • 21. Chimeric mouse model for the infection of hepatitis B and C viruses.
    Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM
    PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool.
    Bukh J; Apgar CL; Engle R; Govindarajan S; Hegerich PA; Tellier R; Wong DC; Elkins R; Kew MC
    J Infect Dis; 1998 Oct; 178(4):1193-7. PubMed ID: 9806059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.
    Dahari H; Feinstone SM; Major ME
    Gastroenterology; 2010 Sep; 139(3):965-74. PubMed ID: 20621699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.
    Bassett SE; Thomas DL; Brasky KM; Lanford RE
    J Virol; 1999 Feb; 73(2):1118-26. PubMed ID: 9882313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructure of normal and hepatitis virus infected human and chimpanzee liver: similarities and differences.
    Schaff Z; Eder G; Eder C; Lapis K
    Acta Morphol Hung; 1992; 40(1-4):203-14. PubMed ID: 1365764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a chimpanzee colony for antibodies to hepatitis C virus.
    Lanford RE; Notvall L; Barbosa LH; Eichberg JW
    J Med Virol; 1991 Jul; 34(3):148-53. PubMed ID: 1717646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal Models to Study Hepatitis C Virus Infection.
    Burm R; Collignon L; Mesalam AA; Meuleman P
    Front Immunol; 2018; 9():1032. PubMed ID: 29867998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of improved mouse models for the study of hepatitis C virus.
    Douglas DN; Kneteman NM
    Eur J Pharmacol; 2015 Jul; 759():313-25. PubMed ID: 25814250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections.
    Shoukry NH; Sidney J; Sette A; Walker CM
    J Immunol; 2004 Jan; 172(1):483-92. PubMed ID: 14688358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity elicited by hepatitis C virus.
    Farci P; Orgiana G; Purcell RH
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S9-12. PubMed ID: 8730469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of the use of chimpanzees in hepatitis C research past, present and future: 2. Alternative replacement methods.
    Bailey J
    Altern Lab Anim; 2010 Dec; 38(6):471-94. PubMed ID: 21275471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model.
    Chen CM; He Y; Lu L; Lim HB; Tripathi RL; Middleton T; Hernandez LE; Beno DW; Long MA; Kati WM; Bosse TD; Larson DP; Wagner R; Lanford RE; Kohlbrenner WE; Kempf DJ; Pilot-Matias TJ; Molla A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4290-6. PubMed ID: 17908950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees.
    Shata MT; Anthony DD; Carlson NL; Andrus L; Brotman B; Tricoche N; McCormack P; Prince A
    J Viral Hepat; 2002 Nov; 9(6):400-10. PubMed ID: 12431201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
    Hartlage AS; Walker CM; Kapoor A
    J Virol; 2020 May; 94(10):. PubMed ID: 32102885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
    Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
    Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the TCR beta variable gene repertoire in chimpanzees: identification of functional homologs to human pseudogenes.
    Meyer-Olson D; Brady KW; Blackard JT; Allen TM; Islam S; Shoukry NH; Hartman K; Walker CM; Kalams SA
    J Immunol; 2003 Apr; 170(8):4161-9. PubMed ID: 12682248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees.
    Bassett SE; Di Bisceglie AM; Bacon BR; Sharp RM; Govindarajan S; Hubbard GB; Brasky KM; Lanford RE
    Hepatology; 1999 Jun; 29(6):1884-92. PubMed ID: 10347134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in experimental systems to study hepatitis C virus in vitro and in vivo.
    Catanese MT; Dorner M
    Virology; 2015 May; 479-480():221-33. PubMed ID: 25847726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects for a vaccine against the hepatitis C virus.
    Houghton M; Abrignani S
    Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.